BackSage Therapeutics Overview

Sage Therapeutics Research & Development

Research & Development expenses for SAGE.

Quarterly R&D Expenses

$23.92M
↓ 61.77% YoY

As of Jun 30, 2025

Annual R&D Expenses (TTM)

$138.27M
↓ 53.99% YoY

Trailing 12 months ending Jun 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin